All Insights
Showing 109 - 120 of 243
Life Sciences and Healthcare
Are European advertising laws ready for patient support programmes?
The legal situation in Europe regarding advertisement of PSPs is highly fragmented with different jurisdictions taking varying approaches to address
Intellectual property
Trade secrets remain the sticking point in global debate over a vaccine IP waiver
A consensus on the vaccine IP waiver is yet to be reached, but will the cancellation of WTO's 12th Ministerial
Intellectual property
Supreme Court gives certainty to patentees in unlawful means economic tort claims
Dealing requirement upheld as an essential component of the tort, leaving intact the current system for litigating patents in the
COP27
COP26 | Energy Day
Welcome to the fourth instalment of our daily COP26 updates: a digest of what is on the agenda each day
Sustainable disruption: 12 decarbonising technologies for cities
Can sustainable disruption and technology deliver decarbonised cities?
Against the backdrop of COP26, the reduction of carbon emissions in cities and identifying methodology, technology and investment to achieve
COP27
COP26 | World Leaders' Summit begins
Welcome to the first instalment of our daily COP26 updates: a digest of what is on the agenda each day
Life Sciences and Healthcare
EUIPO trade mark decision makes protection for medical devices harder to achieve
Boehringer's EU shape trade mark for its HandiHaler declared invalid for performing a technical function
Sustainable disruption: 12 decarbonising technologies for cities
Sustainable disruption: 12 decarbonising technologies for cities
New research by Economist Impact , supported by Osborne Clarke, has identified 12 technologies that can help cities achieve their
Life Sciences and Healthcare
UK sets out plans to diverge from EU regime on gene editing in plants
The government has signalled its intention to pave the way for gene-edited crops following a consultation on departing from EU
Life Sciences and Healthcare
The government has vision for the UK as the world's leading hub for life sciences
Details on the funding of the 10-year strategy, which builds on the UK's world-class capability and on lessons from the
Hemp tea - the fine line between food and narcotics
The first article from our series "Cannabis - the 'green gold' from a legal perspective"
